Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

NCT01924169 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Hematologic Disorder

Interventions

DRUG: Lenalidomide
BIOLOGICAL: Influenza Vaccine
BIOLOGICAL: Pneumovax Vaccine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]